I’m incurring ample risk with large positions in such biotech companies as RVNC and ENTA. Hence, I allocate a significant portion of my portfolio to “defensive” names like WY, ABT, and (most defensive of all) VMATX.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.